🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Surgery Partners, Inc.

SGRY Healthcare
$13.6 $-0.63 (-4.49%)
Market Cap: $1.76 B
Gurus Holding
5
Popularity Rank
#1733
% of Shares Held
0.96%
Net Activity (Q2 2026)
-$6.16 M

Guru Ownership Trend

Guru Analysis for Surgery Partners, Inc. (SGRY)

Surgery Partners, Inc. (SGRY), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q2 2026, a total of 5 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $16.9 M.

Top institutional holders include Howard Marks and Paul Tudor Jones.

Institutional sentiment is currently Slightly Bearish. This is evidenced by a $6.16 M net outflow during the quarter.

Recent activity highlights Cliff Asness who increased their stake by 286.1%. Conversely, Paul Tudor Jones reduced exposure by 43.0%.

Key Holders

Recent Activity Breakdown (Q2 2026)

+$17.25 M
Total Buy Value
New Buys 2
Additions 1
-$23.41 M
Total Sell Value
Reductions 1
Sold Out 1

Guru Consensus (Q2 2026)

Based on recent activity
Net Sellers
2
Net Buyers
3

FAQs for Surgery Partners, Inc. (SGRY)

Major holders include Howard Marks ($14.49 M), Paul Tudor Jones ($2.59 M), Renaissance Technologies (RenTech) ($2.19 M). According to the latest reported data, 5 tracked investment managers collectively hold approximately 1.24 M shares.

According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $6.16 M, with 3 managers increasing positions and 2 managers reducing holdings.

During the most recent reporting period, 1 managers trimmed their positions, while 1 fully exited SGRY. The total reported sell value was $23.41 M.

Yes, 2 managers opened new positions in SGRY, and 1 increased their existing holdings. The total reported buy value was $17.25 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.20% New Buy 862,588 $14.49 M Q2 2026
0.00% Reduce -43.0% 153,926 $2.59 M Q2 2026
0.00% New Buy 130,100 $2.19 M Q2 2026
0.01% 50,000 $840,000 Q2 2026
0.00% Add 286.1% 46,155 $775,404 Q2 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form